King's College London

Research portal

Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis - Reply to Jacobs & Ryan comment

Research output: Contribution to journalLetterpeer-review

Victoria Speed, Lara N. Roberts, Roopen Arya, Jignesh P. Patel

Original languageEnglish
Pages (from-to)872-873
Number of pages2
JournalJournal of Thrombosis and Haemostasis
Issue number3
Early online date2 Mar 2021
E-pub ahead of print2 Mar 2021
PublishedMar 2021

Bibliographical note

Funding Information: V. Speed declares no competing interests. Dr. Roberts has received speaker fees and travel grant from Bayer, and investigator‐initiated research grant and travel grant from Sanofi. Dr. Arya reports grants from Bayer; personal fees from Bayer, Pfizer, Medtronic, and Sanofi; and nonfinancial support from Bayer, Pfizer, and Sanofi. Dr. Patel has received an investigator‐initiated research grant from Bayer. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

King's Authors

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454